https://sciex.com/content/SCIEX/na/us/en


To Switch or Not to Switch? That is the Question.

Aug 23, 2019 | Blogs, Environmental / Industrial, Food / Beverage | 0 comments

Why Polarity Switching Matters

The Basics
In today’s busy analytical laboratories, productivity and high sample throughput are constant demands. More samples need to be analyzed in a shorter timeframe. Laboratories must work to use equipment at its maximum capacity, and methods must be optimized.

With liquid chromatography-mass spectrometry (LC-MS), the chromatography separation has the capacity to resolve a certain number of compounds in a specified period of time. Generally, the shorter the LC run time, the poorer the chromatographic resolution. This potentially affects the MS data quality for those analytes. This is true even for high capacity LC columns, such as those for ultra-high-performance liquid chromatography (UHPLC). 

With an MS detector—let’s say a triple quadrupole MS—you can overcome some of the chromatography shortfalls by using a highly-specific data acquisition method such as Selected Reaction Monitoring (SRM). This is also known as Multiple Reaction Monitoring (MRM) when more than one reaction is involved. The approach allows compounds to be identified and tracked by a specific precursor to product ion transition, or MRM. As the term “multiple” suggests, you can run concurrent compound transitions in virtually the same time frame (within a few milliseconds). Because each transition is unique to a compound, MRM is a highly specific, sensitive, and efficient way of quantifying an analyte.

With a SCIEX triple quadrupole, the unique features of the acquisition software allow the method to be finely optimized to achieve the right number of data points for accurate and precise quantification of chromatographic peaks. This is a feature called Scheduled MRM™ Pro algorithm. It provides a very efficient way of analyzing 100s of analytes within the necessary duty cycle.

The Polarity Question
What if you need a single LC-MS/MS method to analyze compounds with positive and negative ionization states simultaneously? And what if you need to look at both ionization modes while maintaining a high duty cycle, high selectivity, high sensitivity, and chromatographic peak shape integrity?

Well, MS instruments such as the mid-range SCIEX Triple Quad™ 5500+ LC-MS/MS System – QTRAP® Ready or high-end SCIEX Triple Quad™ 6500+ LC-MS/MS System. Both these instruments have detector technology that allows a single method with positive/negative ion switching to run without compromising your data quality.

In the past, MRM conditions were optimized by choosing dwell times that wouldn’t affect the duty cycle of the experiment—which reduced sensitivity and affected detection levels. This generally meant, shorter dwell times for a particular MRM would result in lower accuracy in peak detection and a much higher detection limit.

With the new data acquisition architecture, excellent software algorithms, and powerful electronics, both the SCIEX 5500+ and 6500+ systems can reduce the polarity switching time from 50 milliseconds to 5 milliseconds while maintaining performance characteristics. This ultimately gives an analytical chemist the ability to analyze more compounds in the same amount of time!

See it in action with these workflows:

SCIEX 5500+ System

SCIEX 6500+ System

Questions and answers to help improve your mycotoxin analysis

During a recent webinar I shared method details for mycotoxin analysis on the SCIEX 7500 system. In this blog i will share the Q&A for the submitted questions that we did not have chance to answer during the live webinar.

A 2-fold revolution: MS approaches for the bioanalysis of oligonucleotide therapeutics

In 1998, the US Food and Drug Administration (FDA) approved fomivirsen as the first therapeutic oligonucleotide therapeutic. This approval marked a revolution of mechanism of action discovered decades before finally coming to fruition. Since then, the landscape of chemical modifications of oligonucleotides, conjugations and formulations has evolved tremendously, contributing to improvements in stability, efficacy and safety. Today, more than a dozen antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) drugs are on the market, most of which are designated as orphan drugs for treating rare genetic diseases.

Is “right first time, every time” a pipedream for metabolite identification by LC-MS?

If we lived in an ideal world, it would be possible to unambiguously identify metabolites using a single analytical experiment. This analytical technique would need to be efficient and easily generate the information needed from a routine assay that is also robust, enabling confident decision-making during drug discovery.

Posted by

Ashley Sage is the Senior Manager for Global Portfolio and Technology Strategic Marketing at SCIEX. He is responsible for looking after the strategic marketing campaigns for the product and technology portfolio. Most recently, Ashley was involved in the Generation Quant video creation and campaign. In his free time, Ashley enjoys golfing and spending time with his family.

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial